J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...

近日，盈康一生四川友谊医院心内科收到一位冠心病患冠脉支架植入术后送来的锦旗。这背后承载的不仅是医患情谊，更揭示了冠心病防治的重要性。 冠心病（Coronary Artery Disease, ...

BACKGROUND: Shared genetic and lifestyle risk factors may underlie the development of both coronary artery disease (CAD) and ...

CAD is the leading cause of death worldwide. While the symptoms and signs of coronary artery disease are noted in the advanced state of disease, most individuals with coronary artery disease show ...

For decades, the clinical approach to coronary artery disease has been centred on the acute effects of coronary occlusion and ...

For decades, the management of coronary artery disease has focused on epicardial obstruction and ischaemia, which is often recognised too late for long-term intervention. This approach limits the ...

Using genetically predicted metabolic reaction fluxes, the authors identify reactions that can amplify or buffer the effect ...

Results from the company’s observational trial of more than 3,500 patients found that while disease burden was higher in men, ...

Johnson & Johnson MedTech‘s  Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.